Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine

By Dazzi L.   Seu E.   Cherchi G.   Biggio G.  

European Journal of Pharmacology, Vol. 476, Iss. 1, 2003-08 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite

Reboxetine: the first selective noradrenaline re-uptake inhibitor

By Kasper S.   Giamal N.E.   Hilger E.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 771-782

Informa Healthcare

Access to resources Recommend Favorite

The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor

By Kielbasa William   Tesfaye Eshetu   Luffer-Atlas Debra   Mitchell Malcolm   Turik Michael  

European Journal of Clinical Pharmacology, Vol. 69, Iss. 12, 2013-12 ,pp. : 2011-2019

Springer Publishing Company

Access to resources Recommend Favorite

Combined treatment with serotonin reuptake selective inhibitors in depression (II). Aspects concerning tolerance and toxicity in clinical practice

By Loza A.A.S.   Valverde J.I.F.   Montes M.J.R..   Martiacute nez M.L.D.   Caballero J.L.V..   Docio E.Q.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 292-293

Elsevier

Access to resources Recommend Favorite

Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression

By  

Current Pharmacogenomics, Vol. 1, Iss. 1, 2003-03 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite